NCT06374745 An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol
| NCT ID | NCT06374745 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Lymphedema |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2015-01-02 |
| Primary Completion | 2035-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2015-01-02 with a primary completion date of 2035-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the investigators is to develop an integrated algorithm for surgical treatment of chronic lymphedema after breast cancer surgery. This will be achieved by retrospectively analysing a subgroup of patients who had breast cancer-related surgery prior to lymphedema.
Eligibility Criteria
Inclusion Criteria: * status post breast cancer or status post another type of cancer or status post no cancer * chronic lymphedema - lymphedema lasting over three months - present prior to surgical treatment * one type of surgical procedure for treatment of chronic lymphedema or a combination of surgical procedures for treatment of chronic lymphedema was performed * one or any combination of the following surgical procedures was used in each individual patient: Lymph Node-Vein Anastomosis (LNVA) , Lymphaticovenous Anastomosis (LVA), Tumescent Liposuction (TL), Vascularized Lymph Node Transfer (VLNT) and/or Water-Assisted Liposuction (WAL) Exclusion Criteria: * inclusion criteria not met * loss to follow-up (data not successfully collected)
Contact & Investigator
Elisabeth A Kappos, PD Dr. med
PRINCIPAL INVESTIGATOR
USB
Frequently Asked Questions
Who can join the NCT06374745 clinical trial?
This trial is open to participants of all sexes, studying Lymphedema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06374745 currently recruiting?
Yes, NCT06374745 is actively recruiting participants. Contact the research team at elisabeth.kappos@usb.ch for enrollment information.
Where is the NCT06374745 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT06374745 clinical trial?
NCT06374745 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Elisabeth A Kappos, PD Dr. med at USB. The trial plans to enroll 500 participants.